Neurones S.A.
NRO.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$880.2M
Close$
$61.33
71.5% upside
Current Fair Value
71.5% upsideUndervalued by 71.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $880.20 Million |
|---|---|
| Enterprise Value | $647.27 Million |
| Dividend Yield | $1.40 (3.87%) |
| Earnings per Share | $2.14 |
| Beta | 0.46 |
| Outstanding Shares | 29,307,000 |
Return
| Return on Equity | 28.18% |
|---|---|
| Return on Assets | 14.52% |
| Return on Invested Capital | 32.72% |
Valuation & Multiples
| P/E Ratio | 15.88 |
|---|---|
| PEG | 112.63 |
| Price to Sales | 0.62 |
| Price to Book Ratio | 2.55 |
| Enterprise Value to Revenue | 0.38 |
| Enterprise Value to EBIT | 4.23 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 9, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$454.80 M
Average shareholder expectationNext Earnings Call
Expected Date
March 10, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$457.71 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Neurones S.A.
7,208 employees
CEO: Luc de Chammard Neurones S.A., an information technology (IT) services firm established in Nanterre, France in 1984, provides its comprehensive expertise to clients both domestically and across international markets. The company specializes in a broad a...